首页 › 基金 › SUPERSTRING CAPITAL MANAGEMENT LP › VIR

SUPERSTRING CAPITAL MANAGEMENT LP 对 VIR 的持仓历史

VIR BIOTECHNOLOGY INC · 医疗保健

SUPERSTRING CAPITAL MANAGEMENT LP 在 Q2 2026 的 13F 申报中披露持有 VIR(VIR BIOTECHNOLOGY INC)853,685 股,市值约 US$8.7M,约占其申报组合的 5.49%,在其申报持仓中市值排名第 8 位。 SUPERSTRING CAPITAL MANAGEMENT LP 最近 4 个申报季度中有 3 个季度披露了 VIR 持仓,最早可追溯至 Q3 2025。

最新持仓 (Q2 2026)853.68K 股
申报持仓市值$8.70M
组合权重5.49%
首次申报Q3 2025
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

SUPERSTRING CAPITAL MANAGEMENT LP 对 VIR 的持仓演变

SUPERSTRING CAPITAL MANAGEMENT LP 于 Q3 2025 首次披露 VIR 持仓:150,312 股(约 US$858K)。 该持仓在 Q2 2026 达到峰值 853,685 股,市值约 US$8.7M。 在 3 次申报中,SUPERSTRING CAPITAL MANAGEMENT LP 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 853,685 股、市值约 US$8.7M,环比增持 123,137 股。。

逐季持仓明细

季度股数金额变化
Q3 2025 150.31K $858.28K 新进
Q1 2026 730.55K $6.55M 新进
Q2 2026 853.68K $8.70M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 VIR 与 13F 数据

VIR(VIR BIOTECHNOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 VIR,申报仓位最大的包括:ARCH Venture Management, LLC (US$129.4M), SB INVESTMENT ADVISERS (UK) LTD (US$111.6M), GSK plc (US$87.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 VIR 的基金

查看 VIR 的全部基金持有人 →

常见问题

How long has SUPERSTRING CAPITAL MANAGEMENT LP held VIR?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed VIR holdings in 3 of the last 4 reported quarters, going back to Q3 2025.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in VIR?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 853.68K shares of VIR (VIR BIOTECHNOLOGY INC), valued at $8.70M, representing 5.49% of its reported portfolio and ranking #8.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling VIR?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in VIR. The position peaked in Q2 2026 at 853.68K shares.

Which other funds hold VIR?

Other major institutional holders of VIR include ARCH Venture Management, LLC, SB INVESTMENT ADVISERS (UK) LTD, GSK plc, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.